Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Backed by the Economic Development Board (EDB), the hub was launched on Nov 14 at the Lilly Digital Health and Lilly Centre ...

The centre will improve the quality of medical research and explore new medicine. Read more at straitstimes.com.

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

"We are delighted with Eli Lilly's decision to establish its Digital Health ... dementia and inflammatory diseases such as ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...

The drug is manufactured using yeast and DNA technology ... The Danish drugmaker and rival Eli Lilly have together sued ...

Rival drugs from Eli Lilly and Viking Therapeutics also target GIPR ... is that Amgen has much more experience with this drug than what was published in the February paper," he said in a report.